Literature DB >> 9248850

Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation.

R Grossmann1, J Babin-Ebell, M Misoph, S Schwender, K Neukam, T Hickethier, O Elert, F Keller.   

Abstract

During cardiopulmonary bypass (CPB) mechanical stress and the contact of blood with artificial surfaces lead to the activation of pro- and anticoagulant systems and the complement cascade, and to changes in cellular components. This phenomenon causes the "postperfusion-syndrome", with leukocytosis, increased capillary permeability, accumulation of interstitial fluid, and organ dysfunction. In this study, we focused on the influence of the extracorporeal circulation, sternotomy, and heparin administration on the activation of coagulation and fibrinolysis. In 15 patients we investigated coagulation parameters before, during and post CPB, i.e., fibrinogen, antithrombin (AT) III, thrombin-antithrombin complex (TAT), prothrombin fragments F1 + 2 (F1 + 2), factor (F) XIIa, tissue factor (TF), and parameters of the fibrinolytic system, i.e., plasmin-antiplasmin-complex (PAP), D-dimer, tissue-plasminogen-activator (tPA), urokinase-type plasminogen activator (uPA), and plasminogen-activator inhibitor type 1 (PAI 1). The results demonstrate distinct alterations in the above mentioned parameters. Despite administration of a high dose of heparin (activated clotting time [ACT] > 450s) combined with a low dose of aprotinin, activation of the coagulation and fibrinolytic pathways was observed. We found this activation was mainly caused by CPB and not by sternotomy. The activation of coagulation was due to foreign surface contact (F XII => F XIIa) as well as to an effect of tissue factor release in the late phase of CPB. The enhanced fibrinolytic activity during CPB was, at least in part, caused by tPA and was followed by PAI 1 release.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9248850     DOI: 10.1007/bf01747190

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

1.  Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.

Authors:  J Borowiec; S Thelin; L Bagge; L Nilsson; P Venge; H E Hansson
Journal:  J Thorac Cardiovasc Surg       Date:  1992-09       Impact factor: 5.209

2.  Effects of pulsatile and nonpulsatile perfusion mode during extracorporeal circulation--a comparative clinical study.

Authors:  F Dapper; H Neppl; G Wozniak; I Strube; B Zickmann; F W Hehrlein; H Neuhof
Journal:  Thorac Cardiovasc Surg       Date:  1992-12       Impact factor: 1.827

3.  Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.

Authors:  Y Sakata; S Curriden; D Lawrence; J H Griffin; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?

Authors:  B E Steinbrueckner; U Steigerwald; F Keller; K Neukam; O Elert; J Babin-Ebell
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

5.  Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor.

Authors:  J Butler; D Parker; R Pillai; S Westaby; D J Shale; G M Rocker
Journal:  J Thorac Cardiovasc Surg       Date:  1993-01       Impact factor: 5.209

6.  Hemostasis changes during cardiopulmonary bypass surgery.

Authors:  E F Mammen; M H Koets; B C Washington; L W Wolk; J M Brown; M Burdick; N R Selik; R F Wilson
Journal:  Semin Thromb Hemost       Date:  1985-07       Impact factor: 4.180

7.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.

Authors:  D E Chenoweth; S W Cooper; T E Hugli; R W Stewart; E H Blackstone; J W Kirklin
Journal:  N Engl J Med       Date:  1981-02-26       Impact factor: 91.245

8.  Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator.

Authors:  J Stibbe; C Kluft; E J Brommer; M Gomes; D S de Jong; J Nauta
Journal:  Eur J Clin Invest       Date:  1984-10       Impact factor: 4.686

9.  Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.

Authors:  J A Páramo; J Rifón; R Llorens; J Casares; M J Paloma; E Rocha
Journal:  Haemostasis       Date:  1991

Review 10.  Inflammatory mediators and their influence on haemostasis.

Authors:  A Salgado; J L Bóveda; J Monasterio; R M Segura; M Mourelle; J Gómez-Jiménez; R Peracaula
Journal:  Haemostasis       Date:  1994 Mar-Apr
View more
  5 in total

1.  Characterization of von Willebrand factor in primary pulmonary hypertension.

Authors:  M T Collados; J Sandoval; S López; F A Massó; A Páez; J R Borbolla; L F Montaño
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Association between 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene with stroke or encephalopathy after cardiac surgery.

Authors:  Gonzalo Sirgo; José Luis Pérez-Vela; Pablo Morales; Manuel Del Rey; Joan Vendrell; Cristina Gutierrez; Jordi Rello
Journal:  Intensive Care Med       Date:  2006-03-01       Impact factor: 17.440

3.  Interindividual variations in cytokine levels following cardiopulmonary bypass.

Authors:  M Misoph; J Babin-Ebell
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

4.  Reduced release of tissue factor by application of a centrifugal pump during cardiopulmonary bypass.

Authors:  J Babin-Ebell; M Misoph; W Müllges; K Neukam; O Elert
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

5.  Initial experience with recombinant antithrombin to treat antithrombin deficiency in patients on extracorporeal membrane oxygenation.

Authors:  Kevin S Niimi; Jeffrey J Fanning
Journal:  J Extra Corpor Technol       Date:  2014-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.